Geron slammed in early trading

Traders pummel Geron (GERN) after its disclosure of the FDA-mandated clinical hold. Shares are down 67% on 8.5M shares.

Comments (3)
  • richroehl
    , contributor
    Comments (18) | Send Message
    never had any faith in them after they gave up on stem cells and they kept trying to find something that their telemorase inhibitor worked on.
    12 Mar 2014, 06:13 PM Reply Like
  • starcorral
    , contributor
    Comments (1743) | Send Message
    Panic: It takes money from one posket and puts it in another. I'd like to thank everyone who made this buying opportunity available. Having one's basis cut in half means accepting a big loss in stride, but I own more Geron now than ever before with a much lower basis.


    The FDA is doing their Job; Geron will follow suit. Imetelstat rids the body of a lethal substance. Now we'll see if there can be some sort of mitigation that balances the equation in favor of restarting the trials.
    12 Mar 2014, 06:53 PM Reply Like
  • Charles FugittSR
    , contributor
    Comments (4) | Send Message
    Geron keep going you can do it 'and maybe save the humen race'gods on your side. charles
    9 May 2014, 04:47 PM Reply Like
DJIA (DIA) S&P 500 (SPY)
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs